Noverant CEO Appointed to Board of Pharmaceutical Calibrations and Instrumentation (PCI)

Press Releases
Written By

Noverant is pleased to announce that Pharmaceutical Calibrations and Instrumentation (PCI), a leading provider of calibration and maintenance services to the Life Sciences industry, has appointed Noverant executive F. Gozzo, Ph.D to its board effective June 23, 2014.

PCI was founded in 1996 with a vision of becoming the best consulting and technical services firm in the life sciences industry. The company’s core expertise is calibration and maintenance compliance for FDA-regulated manufacturing facilities and laboratories.  With operations throughout the United States, PCI provides a variety of services including process and laboratory instruments, pipette calibration, data analysis and consulting, commissioning and metrology lab services.

Further details of the announcement are available at Gozzo Joins PCI Board.

About Noverant

Noverant is a leader in web-based information, training and compliance management applications, serving regulated and training-intensive clients on six continents. For more information, visit www.noverant.com.

Previous

Noverant Adds Government-Approved Data Centers In Canada
Next

MROs Need Cost-Effective LMS - Jet Aviation Selects Noverant